CMS Open Payments · Program Year 2024
BonaliveInc
BonaliveInc reported $3,332.23 across General Payments, Research, and Ownership to 34 physicians and teaching hospitals across 34 transactions.
- $3.3K Below-median payer
- All-tracks total
- 34 Below-median volume
- Transactions
- 34 Below-median reach
- Recipients
- #1758
- of 1,925 companies
BonaliveInc reported $3,332.23 across all CMS Open Payments tracks (General + Research + Ownership) to 34 physicians and teaching hospitals in Program Year 2024 - ranking #1758 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,332.23, averaging $98.01 per recipient.
BonaliveInc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bonaliveinc BonaliveInc
$3.3K · #1758/1,925 · 0.0% industry · PY2024
- TOT $3.3K
- RANK #1758
- SHARE 0.0%
- TXN 34
- RCP 34
- CAT 1
- GEN $3.3K
- TOP1 5.4%
- PY 2024
Volume peers
Nearest volume peer: Meitheal Pharmaceuticals, Inc. ($3.3K)
BonaliveInc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for BonaliveInc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For BonaliveInc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $3.3K across 34 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads BonaliveInc's 1-category general-payment breakdown at $3.3K, 100.0% of the reported total.
How BonaliveInc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $3.3K | 34 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $710.36 (21.3%) of $3,332.23 in this company's General Payments records across 34 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for BonaliveInc
The five named recipients with the highest reported General Payments from this company
- 1
Dipak Balaji Ramkumar
$180.98 across 1 reported transactions
- 2
Christina J Gutowski
$151.18 across 1 reported transactions
- 3
William Ryan
$151.18 across 1 reported transactions
- 4
Chase Alexander Horsager
$113.51 across 1 reported transactions
- 5
Ivan Z Liu
$113.51 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
BonaliveInc's spend rank (#1758 of 1,925, bottom 9% by spend) and concentration rank (#1,429 of 1,838, bottom 22% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Checkpoint Surgical, Inc : $293.7K total payments, HHI 348
- Medline Industries LP : $1.9M total payments, HHI 347
- Olympus Corporation : $904.0K total payments, HHI 343
- Coherus Biosciences Inc. : $361.8K total payments, HHI 343
- Orphalan Inc : $61.9K total payments, HHI 342
- Dutch Ophthalmic, USA : $85.0K total payments, HHI 342
- BonaliveInc (this company) : $3.3K total payments, HHI 342
- Davol Inc. : $4.4M total payments, HHI 337
- Eli Lilly Export S.A. Puerto Rico Branch : $47.2K total payments, HHI 334
- Profound Medical Corp. : $125.2K total payments, HHI 329
- Argenx US, Inc. : $3.5M total payments, HHI 327
- DC Dental, LLC : $12.9K total payments, HHI 327
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as BonaliveInc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about BonaliveInc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with BonaliveInc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Northern X-Ray Company
Pillar Biosciences, Inc
Xiros Inc
Intersurgical Inc
Lifeward, Inc.
Put this to use
BonaliveInc ranks #1758 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just BonaliveInc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.